Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Dual-Axis Automation Feature Added to Electron Tomography System for Life Science Research

By LabMedica International staff writers
Posted on 20 Nov 2008
Automated dual-axis acquisition and reconstruction features have been developed, extending the capability and accuracy of electron tomography imaging for three-dimensional (3D) biologic ultrastructures.

Fei Co. More...
(Hillsboro, OR, USA), a leading provider of high-resolution imaging and analysis systems, recently released its Xplore3D software package, updated to include data acquisition and reconstruction for dual-axis electron tomography. The new capability provides more complete information for the reconstruction of complex biologic ultra-structures from high-resolution scanning/transmission electron microscopy (S/TEM).

Xplore3D's sophisticated automation and precise specimen positioning capabilities allow users to automatically acquire tomography tilt series images from an initial tilt axis and a second tilt axis, after a sample rotation. Acquiring tilt series from two axes enables users to gain more information from the sample, thereby minimizing the "missing wedge” problem common to all single tilt series tomography. After automated dual-axis acquisition, Xplore3D also enables automated dual-axis tomogram reconstruction. Its dual-axis capability enables users to generate highly accurate tomograms as simply as possible. Xplore3D is available now and integrated with FEI Tecnai and Titan Krios TEMs.

"We are committed to providing the best, easy-to-use solutions for high-resolution imaging and analysis of biological ultrastructure,” said Matthew Harris, vice president and general manager of FEI's Life Science Division. "Xplore3D with dual-axis tomography improves the quality of the tomographic analysis by providing additional information for reconstructions. It is part of FEI's commitment to provide wide-ranging imaging solutions for life scientists. Our hardware and software solutions give researchers a complete cryo-TEM tomography package that allows them to focus on making ground-breaking discoveries.”

Single-axis S/TEM tomography data suffer from the existence of a "missing wedge” due to the geometry of samples and stage; images can usually only be acquired for tilt angles in a range of ± 70º. In 3D reconstruction, this gives rise to artifacts and directional dependencies in resolution and contrast. To reduce these shortcomings, samples are often rotated by about 90º in the holder and a second tilt series is acquired (dual-axis tomography). The "missing wedge” is thus reduced to a "missing pyramid.” Extreme precision in the compucentric stage is required to maintain the point of interest at the same location within the field of view as the sample tilts during the imaging sequences. FEI's Xplore3D adds automated dual-axis acquisition and reconstruction capabilities to minimize the missing wedge problem and optimize the accuracy of any tomographic reconstruction.

Fei is a world leader in pioneering technologies and applications that provide imaging systems for 3D characterization, analysis, and modification/prototyping with resolutions down to the sub-Ångström level. The company's customers, working in advanced research and manufacturing, are supported by field-experienced applications specialists. They have open access to FEI's prestigious global user network so they can succeed in accelerating nanoscale discovery and contribute to better living through new product commercialization.

Related Links:
Fei



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.